Beard oil

Manufacturer
Guangdong Bisutang Biotechnology Co., Ltd.
Effective date
2024-10-23
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:28:53

Label at a glance#

ProductBeard oil
Active ingredientMINERAL OIL
Label structure10 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

MINERAL OIL

OTC - PURPOSE SECTION

After cleansing andtoning, take an appropriate amount ofthis product and apply it evenly on theface, massage until absorbed

Ask Doctor

OTC - ASK DOCTOR SECTION

If you have a history of skin allergies or have sensitive skin, it is advisable to consult a doctor before using this product.

DOSAGE & ADMINISTRATION SECTION

Apply once daily to clean face and neck, avoiding the eye area

OTC - WHEN USING SECTION

Avoid contact with eyes and broken skin. If redness, swelling, or irritation occurs, discontinue use immediately and seek medical advice.

WARNINGS SECTION

Risk InformationFor external use only
Mention de risquesPour usage externe seulement
Do not use on damaged or broken skin.
Ne pas utiliser sur la peau endommagée ou avec des lésions
If rash occurs, discontinue use and consult a health care practitioner.
En présence d'une éruption cutanée, cesser l'utilisation et consulter un praticien de soins de santé
When using this product keep out of eyes. Rinse with water to remove.
Eviter tout contact avec les yeux. Rincer a l'eau le cas échéant
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Tenir hors de portée des enfants
En cas d'ingestion, consulter un médecin ou appeler un centre antipoison immédiatement.

INDICATIONS & USAGE SECTION

Temporarily protects and helps relieve dry or cracked skin
Beneficlal for face, hands, body, and legs

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Tenir hors de portée des enfants
En cas d'ingestion, consulter un médecin ou appeler un centre antipoison immédiatement.

INACTIVE INGREDIENT SECTION

MINERAL OIL
ETHYLHEXYL PALMITATE
BISABOLOL
PARFUM
CETYL ETHYLHEXANOATE

ISOHEXADECANE

ANTHEMIS NOBILIS FLOWER OILLAVANDULA ANGUSTIFOLIA (LAVENDER) OILVALERIANA OFFICINALIS ROOT OIL虑CITRUS AURANTIUM AMARA (BITTER ORANGE) LEAFJASMINUM SAMBAC UASMINE) FLOWER OIL
SQUALANE
OLEA EUROPAEA (OLIVE) FRUIT OILTOCOPHERYL ACETATESIMMONDSIA CHINENSIS (JOJOBA) SEED OIL
CI 15850

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84753-019-01Beard oil60 mL in 1 BOTTLE, PLASTICOIL601

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84753-019BEARD OIL OIL [GUANGDONG BISUTANG BIOTECHNOLOGY CO., LTD.]11 package rows20241025_25311dfa-a447-700f-e063-6394a90ae1da.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84753-01984753-019-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
25310b66-8eab-4468-e063-6294a90ac4e125311dfa-a447-700f-e063-6394a90ae1da2024-10-23WarningsExact identifier
spl id: 25310b66-8eab-4468-e063-6294a90ac4e1
spl set id: 25311dfa-a447-700f-e063-6394a90ae1da

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.